Melanoma And Skin Cancer Trials Limited
Clinical trials sponsored by Melanoma And Skin Cancer Trials Limited, explained in plain language.
-
Promising combo targets tough skin cancer
Disease control OngoingThis study tests whether combining the immunotherapy drug avelumab with two types of radiation therapy can help control metastatic Merkel cell carcinoma, a rare and aggressive skin cancer. About 19 adults with advanced disease that has spread will receive the combination treatmen…
Phase: PHASE1, PHASE2 • Sponsor: Melanoma and Skin Cancer Trials Limited • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Transplant patients get new hope against facial skin cancer
Disease control OngoingThis study tests a cream containing sirolimus, applied nightly for 24 weeks, to prevent skin cancer on the face of organ transplant recipients. 146 adults who have had an organ transplant and a past skin cancer are participating. The cream is compared to a placebo to see if it re…
Phase: PHASE3 • Sponsor: Melanoma and Skin Cancer Trials Limited • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Immunotherapy drug avelumab aims to stop merkel cell cancer recurrence in early-stage patients
Disease control OngoingThis study tests whether the immunotherapy drug avelumab can help prevent Merkel cell carcinoma from returning after initial treatment. About 122 adults with stage I to III Merkel cell carcinoma are randomly assigned to receive either avelumab or a placebo. The main goal is to se…
Phase: PHASE2 • Sponsor: Melanoma and Skin Cancer Trials Limited • Aim: Disease control
Last updated May 05, 2026 11:57 UTC